Cargando…

Efficacy and safety of alogliptin in a pediatric patient with maturity-onset diabetes of the young type 1

The first-line pharmacological treatment for patients with maturity-onset diabetes of the young type 1 (MODY1) and maturity-onset diabetes of the young type 3 (MODY3) are sulfonylureas (SUs) or insulin. However, several reports have suggested the possibility of using incretin-associated drugs, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tonouchi, Ryosuke, Mine, Yusuke, Aoki, Masako, Okuno, Misako, Suzuki, Junichi, Urakami, Tatsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society for Pediatric Endocrinology 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537215/ https://www.ncbi.nlm.nih.gov/pubmed/28804210 http://dx.doi.org/10.1297/cpe.26.183

Ejemplares similares

Efficacy and safety of switching to insulin glulisine from other rapid-acting insulin analogs in children with type 1 diabetes
por: Urakami, Tatsuhiko, et al.
Publicado: (2015)

Time to peak postprandial glucose levels in childhood-onset diabetic patients analyzed with a continuous glucose monitoring system
por: Suzuki, Junichi, et al.
Publicado: (2013)

Juvenile case with the coexistence of maturity‐onset diabetes of the young 1 and later‐onset latent autoimmune diabetes in youth
por: Yoshida, Kei, et al.
Publicado: (2020)

Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment
por: Urakami, Tatsuhiko
Publicado: (2019)

Basal insulin requirement of youth with type 1 diabetes differs according to age
por: Urakami, Tatsuhiko, et al.
Publicado: (2013)

Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes
por: Urakami, Tatsuhiko, et al.
Publicado: (2021)

Pharmacologic Treatment Strategies in Children with Type 2 Diabetes Mellitus
por: Urakami, Tatsuhiko, et al.
Publicado: (2013)

Efficacy of zinc supplementation on growth and IGF-1 in prepubertal children with idiopathic short statures and low serum zinc levels
por: Yoshida, Kei, et al.
Publicado: (2020)

Comparison of the clinical effects of intermittently scanned and real‐time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study
por: Urakami, Tatsuhiko, et al.
Publicado: (2022)

Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes
por: Urakami, Tatsuhiko, et al.
Publicado: (2023)

The Characteristics Of Abdominal Fat Distribution In Japanese Adolescents With Type 2 Diabetes Mellitus
por: Abe, Yuriko, et al.
Publicado: (2019)

Frequency of dawn phenomenon and its associations with age, HbA1c and diabetes duration in Japanese type 1 diabetes mellitus (T1DM) using the continuous glucose monitoring system (CGMS)
por: Yoshida, Ayako, et al.
Publicado: (2013)

Chromosome 6q24 methylation defects are uncommon in childhood-onset non-autoimmune diabetes mellitus patients born appropriate- or large-for-gestational age
por: Okuno, Misako, et al.
Publicado: (2016)

Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus
por: Takeda, Hiroshi, et al.
Publicado: (2019)

Pregnancy outcome of Japanese patients with glucokinase–maturity‐onset diabetes of the young
por: Hosokawa, Yuki, et al.
Publicado: (2019)

Allergic contact dermatitis caused by isobornyl acrylate when using the FreeStyle(®) Libre
por: Mine, Yusuke, et al.
Publicado: (2019)

Endocrinopathies in a boy with cryptic copy-number variations on 4q, 7q and Xp
por: Okuno, Misako, et al.
Publicado: (2015)

Ethnic Differences in Efficacy and Safety of Alogliptin: A Systematic Review and Meta-Analysis
por: Cai, Yuli, et al.
Publicado: (2017)

Insulin glargine in pediatric patients with type 1 diabetes in Japan
por: Urakami, Tatsuhiko, et al.
Publicado: (2014)

Association of Plasma Cortisol Levels with Gestational Age and Anthropometric Values at Birth in Preterm Infants
por: Aoki, Masako, et al.
Publicado: (2022)

Efficacy and Safety of Alogliptin in Patients With Type 2 Diabetes: Analysis of the ATTAK-J Study
por: Takeda, Hiroshi, et al.
Publicado: (2016)

Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
por: Shigematsu, Nao, et al.
Publicado: (2020)

Enhancing Pancreatic Beta-Cell Regeneration In Vivo with Pioglitazone and Alogliptin
por: Yin, Hao, et al.
Publicado: (2013)

New insights into the pharmacological treatment of pediatric patients with type 2 diabetes
por: Urakami, Tatsuhiko
Publicado: (2018)

Pathogenic Characteristics at Diagnosis in Young Children with Type 1 Diabetes Presenting Prior to 5 Years of Age
por: Urakami, Tatsuhiko, et al.
Publicado: (2008)

Long-Term Effect of Alogliptin on Glycemic Control in Japanese Patients With Type 2 Diabetes: A 3.5-Year Observational Study
por: Takebayashi, Kohzo, et al.
Publicado: (2017)

Alogliptin benzoate for management of type 2 diabetes
por: Saisho, Yoshifumi
Publicado: (2015)

Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study
por: Mita, Tomoya, et al.
Publicado: (2023)

Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
por: Kim, Hae Jin, et al.
Publicado: (2022)

Alogliptin: a new addition to the class of DPP-4 inhibitors
por: Andukuri, Radha, et al.
Publicado: (2009)

Liquid Chromatographic Determination of Alogliptin in Bulk and in its Pharmaceutical Preparation
por: El-Bagary, Ramzia I., et al.
Publicado: (2012)

Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis
por: Shima, Hisato, et al.
Publicado: (2019)

Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report
por: Del Rio, Teresa, et al.
Publicado: (2023)

Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index
por: Aoki, Chie, et al.
Publicado: (2017)

Hyperglycemia in pediatric age: could it be maturity onset diabetes of the young? Case reports and review of the literature
por: Cascais, Mafalda, et al.
Publicado: (2019)

Recognition of maturity‐onset diabetes of the young in China
por: Liang, Hua, et al.
Publicado: (2020)

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
por: Kapoor, Shailendra
Publicado: (2012)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Alogliptin improves survival and health of mice on a high‐fat diet
por: Zhu, Biao, et al.
Publicado: (2019)

Effects of metformin and alogliptin on body composition in people with type 2 diabetes
por: Takeshita, Yumie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b7qlqvt956a50kp2o35og22j97